Prescient Therapeutics secures FDA fast track for PTX-100 to advance CTCL treatment strategy
Find out how Prescient Therapeutics’ PTX-100 just gained FDA Fast Track status, accelerating the path to treating relapsed CTCL. Read More
Johnson & Johnson’s next-gen surgical robot OTTAVA enters operating rooms for the first time
Find out how Johnson & Johnson MedTech's OTTAVA robotic surgical system is advancing minimally invasive surgery with its first completed clinical trial cases. Read More
Abbott advances coronary artery disease treatment with new intravascular lithotripsy trial
Abbott’s Coronary Intravascular Lithotripsy (IVL) System gets FDA approval for a clinical trial to enhance coronary artery disease treatment—learn more. Read More
Danone faces quality concerns as FDA recalls International Delight coffee creamers
Danone North America has issued a voluntary recall of over 75,000 bottles of International Delight coffee creamer following reports of product spoilage and illness. The ... Read More
Laplace Interventional advances life-saving heart valve technology with $22m funding round
Laplace Interventional, a Minnesota-based medical device company pioneering transcatheter tricuspid valve replacement technology, has secured $22 million in Series C financing to accelerate the development ... Read More
Sanofi advances flu vaccine production with FDA-approved strains for 2025-26 season
Sanofi has confirmed that it is advancing its flu vaccine production for the 2025-26 flu season, aligning with the US Food and Drug Administration (FDA)-selected ... Read More
AbbVie’s ELAHERE demonstrates 32% reduction in death risk for ovarian cancer patients
A final analysis of the Phase 3 MIRASOL trial has confirmed that ELAHERE (mirvetuximab soravtansine-gynx) provides a significant survival advantage for patients with folate receptor ... Read More
Dr. Reddy’s Laboratories recalls Levetiracetam Injection in U.S. over mislabeling concerns
Dr. Reddy’s Laboratories Limited has initiated a nationwide recall of a batch of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL in the United ... Read More
Capricor Therapeutics advances deramiocel toward FDA approval with priority review
Capricor Therapeutics has reached a significant milestone in its efforts to develop a novel treatment for Duchenne muscular dystrophy cardiomyopathy. The U.S. Food and Drug ... Read More
Biocon Biologics reports positive Phase 3 results for Yesintek, biosimilar to Ustekinumab
Biocon Biologics Ltd., a global leader in biosimilar medicines and a subsidiary of India's pioneering biopharmaceutical giant Biocon Limited, announced promising results from its recent ... Read More